NKTX
Nkarta, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.83
+0.71%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$0.40
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.54
- EPS estimate
- -$0.36
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -11.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $12
- PT range
- $10 – $14
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.36 | -$0.54 | Miss -49.87% | — |
| May 12, 2026 | -$0.39 | -$0.37 | Beat 5.13% | — |
| Mar 25, 2026 | -$0.32 | -$0.37 | Miss -15.62% | — |
| Aug 12, 2025 | -$0.37 | -$0.31 | Beat 16.22% | — |
| May 14, 2025 | -$0.44 | -$0.43 | Beat 2.27% | — |
| Mar 26, 2025 | -$0.41 | -$0.35 | Beat 14.63% | — |
| Nov 7, 2024 | -$0.37 | -$0.39 | Miss -5.41% | — |
| May 9, 2024 | -$0.56 | -$0.58 | Miss -3.57% | — |
| Mar 21, 2024 | -$0.62 | -$0.57 | Beat 8.06% | $10.5M |
| Nov 9, 2023 | -$0.67 | -$0.52 | Beat 22.39% | — |
| Aug 10, 2023 | -$0.69 | -$0.68 | Beat 1.45% | — |
| May 11, 2023 | -$0.71 | -$0.63 | Beat 11.27% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026